DACLIZUMAB vs DACOMITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACLIZUMAB vs DACOMITINIB: Safety Overview
| Metric | DACLIZUMAB | DACOMITINIB |
|---|---|---|
| Total FAERS Reports | 2,801 | 682 |
| Deaths Reported | 193 | 325 |
| Death Rate | 6.9% | 47.7% |
| Hospitalizations | 835 | 168 |
| Average Patient Age | 45.7 yrs | 64.0 yrs |
| % Female Patients | 81.5% | 52.0% |
| FDA Approval Date | N/A | Sep 27, 2018 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |